Fresenius Medical Care's heart and lung group has been awarded a national group purchasing agreement for Mechanical Circulatory Support with Premier, Inc. in the U.S. This agreement specifically covers the Novalung® ECMO System, expanding its availability to Premier member hospitals.
The agreement underscores Fresenius Medical Care's ongoing commitment to advancing critical care solutions, building on its acquisition of Xenios in 2016. This strategic partnership is expected to enhance the company's market presence in mechanical circulatory support.
The collaboration with Premier, Inc. allows Fresenius Medical Care to further integrate its innovative technologies into the broader healthcare system, providing more patients with access to advanced heart and lung therapies.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.